← Back to VTS Methodology
VTS Scoring Log

Blue Sky Peptide

US-based vendor · Operating since 2013· Scored August 2026· blueskypeptide.com

Blue Sky Peptide has operated since 2013, predating most current vendors by years, and carries one of the longest track records in the research peptide space. COAs are documented but inconsistently accessible according to multiple independent review sources - sometimes available on request rather than proactively displayed per product lot. The testing laboratory is not consistently identified, and MS data is not uniformly provided. The operational history is the vendor's strongest VTS signal; documentation standards have not kept pace with what the current market expects.

55 /100
Limited Transparency
Operating since 2013 - longest track record on the current roster. COAs on request rather than proactively published per lot. Testing lab not consistently identified. MS data not uniformly provided.
Dimension Scores
Dimension Max Notes Score
Third-Party Testing Practice 30 Testing present per the sourced comparison data (MS + UV cited). Third-party laboratory 'not always clearly identified' per independent review sources. COAs provided but consistency of third-party independence across the full catalog is not confirmable from public materials. 14/30
Batch Traceability & Verification 20 COAs documented as sometimes available on request rather than proactively displayed per product lot. On-request access is explicitly below the Moderate standard of openly published pre-purchase COAs. Lot-specific linkage not consistently confirmed from independent sources. 9/20
COA Accessibility 15 Available on request rather than proactively published per product lot per multiple independent review sources. This scores below the Moderate standard of openly published and searchable pre-purchase access. 9/15
COA Completeness 15 MS + UV referenced in the sourced comparison data. Independent reviews note MS data 'not uniformly provided alongside HPLC purity figures.' Inconsistency in completeness across the catalog reduces this score. 9/15
Testing Recency 10 Active vendor with ongoing operations. No systematically stale documentation identified. The on-request accessibility model makes independent verification of currency difficult. 6/10
Policy Transparency 5 Active discount (45% off site-wide noted) suggests credit card processing is operational. Reship and refund terms not confirmed from public sources reviewed. Checkout tools described as relatively basic in independent reviews. 3/5
Operational Track Record 5 Operating since 2013 - among the longest operational histories in the research peptide space. Sustained operation through multiple regulatory cycles over 13+ years is a meaningful signal. Maximum score on this dimension. 5/5
Total 55/100
Community Signal
Independent Test Results
No systematic community-commissioned test results identified in recently reviewed forum sources. Longer operational history means older community test data exists but currency is uncertain.
Community Experience
Generally acceptable reputation for fulfillment reliability given the long operational history. Some researcher feedback notes documentation inconsistency as a friction point. The on-request COA model is cited as a negative relative to current market standards by multiple independent reviewers.
Scoring Notes
On-request COA access - below current market standard
Multiple independent review sources note that COAs are sometimes available on request rather than displayed per product lot. The standard that has emerged in the current market - proactively published, batch-specific, pre-purchase accessible COAs - is not consistently met by Blue Sky Peptide. This is the most actionable documentation gap.
Testing lab not consistently identified
The specific testing laboratory is described as 'not always clearly identified' in independent reviews. Without a named lab, cross-verification against an external database is impossible. Naming the lab and publishing COAs pre-purchase would be the highest-impact changes to the score.
Operating since 2013 - the longest track record in the current roster
Blue Sky Peptide has been operating since 2013, predating most current vendors by years. Sustained operation through FDA compounding guidance evolution, WADA list changes, and multiple enforcement cycles across 13+ years is a genuine differentiator. The track record score is at maximum. The Limited band reflects documentation standards, not business history.
Sources: blueskypeptide.com · ironpeakpeptides.com/blue-sky-peptide-review-alternative-2026 · formblends.com/articles/peptide-hub/best-top-10-peptide-companies · r/ScienceBioTechnology community comparison post (August 2026). VTS measures process transparency from publicly available materials only. It is not a certification of product safety, purity, or efficacy. Scored August 2026 - reviewed on a rolling basis as vendor practices change.